Identified a new repairing mechanism of the peripheral nervous system by applyting bioengineering techniques Blog Post

A research group at the Institute of Bioengineering of Catalonia (IBEC) at the Barcelona Science Park has applied a new light-stimulated technique to modulate muscular activity and stimulate cell regeneration of the peripheral nervous system. Thanks to this research, published in Cells, the scientists have discovered that muscle activity can activate the neurons and accelerate their regeneration after an injury. 


AECC backs cancer research involving 3D models at IRB Barcelona Blog Post

The Asociación Española Contra el Cáncer (AECC) –in collaboration with Cancer Research UK (CRUK) and the Fondazione AIRC per la Ricerca sul Cancro (AIRC)– has awarded more than €500,000 euros of funding to an IRB Barcelona project, within the framework of the Accelerator Awards call.  the project will allow researchers to study the complexity and heterogeneity of cancer using culturable mini-cancers, also known as organoids, derived from patients.


Núria Montserrat wins Íñigo Álvarez de Toledo Award for Basic Research Blog Post

Núria Montserrat, ICREA research professor and principal investigator of the “Pluripotency for organ regeneration group” at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park, has unanimously won the XXXI Íñigo Álvarez de Toledo Award for Basic Research granted by the Fundación Renal Íñigo Álvarez de Toledo (FRIA). 


Researchers from CNAG-CRG and IRB Barcelona contribute to the description of the most comprehensive map of cancer genomes Blog Post

The international team of scientists of the ‘Pan-Cancer Analysis of Whole Genomes Project’ (PCAWG) today published 23 studies in the Nature journals, describing the most comprehensive map of cancer genomes from 38 types of tumours to date. Among the 1,300 researchers who have contributed to the project are scientists from the Institute for Research in Biomedicine (IRB Barcelona) and the Centro Nacional de Análisis Genómico (CNAG-CRG) in the Barcelona Science Park.The results are an important step for the development of personalised medicine to treat cancer.


Núria López-Bigas receives the National ‘Doctores Diz Pintado’ Cancer Research Prize Blog Post

Núria López-Bigas, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park, has received the IX National ‘Doctores Diz Pintado’ Cancer Research Prize for her career path. The researcher is the first female scientist to be presented with this prize, which is presented every year by the Fundación de Investigación del Cáncer de la Universidad de la Salamancaa (FICUS)-Centro de Investigación del Cáncer (USAL-CSIC)  to promote and acknowledge the contribution of young Spanish researchers to Cancer Research.


Esteve acquires German pharmaceutical company Riemser and expands its presence in Europe Blog Post

Esteve have come to an agreement to acquire the German pharmaceutical company Riemser. Headquartered in Berlin, Riemser has subsidiaries in the United Kingdom, France, and Spain and is present in nearly 50 countries through alliances with third parties. This acquisition provides Esteve ––which has its Drug Discovery and Preclinical Development Center at the Barcelona Science Park–– with greater pharmaceutical presence in Europe’s main markets and a portfolio of proprietary specialty products for hospital use. 


Researchers from the CNAG-CRG develop a new classification system for tumours Blog Post

Based on the largest study of cancer patients of its kind, scientists at the Centre Nacional d’Anàlisi Genòmica (CNAG-CRG), located in the Barcelona Science Park, have created a new way of classifying tumours. Clinicians can use genome sequencing to assign their patients’ tumours to one of sixteen groups in the new classification system, ten of which provide important information for the diagnosis and treatment of the disease, like whether an individual will respond to immunotherapy. The work is published in PLOS Computational Biology.